A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism. Human molecular genetics, ddac170

Veneri, F. A., Prada, V., Mastrangelo, R., Ferri, C., Nobbio, L., Passalacqua, M., Milanesi, M., Bianchi, F., Del Carro, U., Vallat, J. M., Duong, P., Svaren, J., Schenone, A., Grandis, M., & D’Antonio, M. (2022). A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism. Human Molecular Genetics, 31(24), 4255–4274. https://doi.org/10.1093/hmg/ddac170